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Abstract 
A multiparameter model of the diffusion, antiproliferative assays IC50 and aerobic and 
hypoxic clonogenic assays for a wide range of neutral and radical anion forms of 
tirapazamine (TPZ) analogues has found that: (a) extravascular diffusion is governed by the 
desolvation, lipophilicity, dipole moment and molecular volume, similar to passive and 
facilitated permeation through the blood brain barrier and other cellular membranes, (b) 
hypoxic assay properties of the TPZ analogues show dependencies on the electron affinity, as 
well as lipophilicity and dipole moment and desolvation, similar to other biological processes 
involving permeation of cellular membranes, including nuclear membranes, (c) aerobic 
properties are dependent on the almost exclusively on the electron affinity, consistent with 
electron transfer involving free radicals being dominant with little or no drug permeation of 
membranes, and most likely occurring in the extracellular matrix.   
 
Application of the model to the DNA binding equilibrium constants of TPZ analogues with 
acridine or acridine-like moieties show that ligand water desolvation and lipophilicity are the 
dominant processes governing the DNA intercalation of TPZ analogues. This conclusion is 
consistent with DFT modelling of the complexes formed by TPZ analogues with neutral and 
N-protonated acridine moieties which intercalate with the guanine DNA nucleobases. 
 
A quantum mechanical study has shown that TPZ can form stable complexes with 
cucurbit[7]uril as a precursor to proof of principle of improved TPZ delivery to tumours. 
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1. Introduction 
Solid tumours have characteristic microenvironments as a result of poor vascular supply. The 
microenvironment consists of gradients of oxygen tension, cellular metabolites, nutrients, cell 
growth, and extracellular pH which vary in distance from the vascular supply network. 
Hypoxia is a characteristic of many cancers, and is a poor prognosis marker. Resistance to 
chemotherapy is strongly linked to hypoxia induced reduction in cell proliferation. Hypoxic 
regions of tumours are distant from vascular blood supply, making anti-cancer drug delivery 
a key factor in resistance induced by hypoxia. 
1-6
 [Vaupel 2008-13, Tredan 2007, Minchinton 
2006, Muz 2015]  
 
Hypoxia is a common condition in a majority of malignant tumours and can lead to increased  
vascularisation and metastasis. When a tumour reaches to a critical size the nutrients 
diffusion is insufficient to supply the required amount of oxygen to the inner parts of the 
tumour resulting in hypoxia. The tumour microenvironment influences various cell signalling 
processes involved in tumour angiogenesis, metastasis, and development of the resistance to 
therapies. Hypoxia helps the tumour cells survive by giving them more aggressive 
phenotypes. The degree of hypoxia varies with tumour type and size. 
6
 [Muz 2015] 
Chemotherapy and radiotherapy treatment often encounter strong resistance from hypoxic 
regions inside the tumour. While there a negative correlation between the hypoxic fraction in 
tumours and the efficacy of radiotherapy and chemotherapies, there is also a correlation 
between the hypoxic fraction in tumours and cancer metastasis. 
7
 [Pettersen 2014] 
 
Wardman 2007 
8
 has shown that electron-affinic compounds which react with DNA free 
radicals have the potential to be universally active in combating hypoxia related 
radiosensitizers, and hypoxia specific cytotoxins such as tirapazamine (TPZ) is particularly 
active. Drugs can be selectively delivered to hypoxic tumours using either reductive enzymes 
or radiation produced free radicals to activate drug release from electron-affinic prodrugs 
such as TPZ. TPZ potentiates cell killing with fractionated irradiation. A linear relationship is 
known to exist between the sensitizer concentration required to produce a constant sensitizing 
response (C), and the one electron reduction potential at pH 7 (E
7
): -log C = bo + b1 E
7
. The 
relationship also holds for toxicity as well as sensitization. 
9
 [von Sonntag 2006] Intracellular 
thiols (eg glutathione, cysteine, and protein thiols) are known to have radioprotective 
qualities and suppression of these species can enhance chemotherapeutic efficacy.  
 
TPZ is enzymatically bioreduced to a cytotoxic benzotriazinyl free radical as well as 
producing HO• radicals at very low levels of oxygen. Essentially nearly all of the DNA 
damage caused by TPZ occurs from radical species formed inside the nucleus, and TPZ 
radicals formed outside the nuclei do not contribute to DNA damage. 
10
 [Evans 1998] These 
free radicals cause DNA strand breaks. 
11-13
 [Junnotula 2009, Brown 2004, Yin 2012]. The 
DNA damaging mechanism of TPZ and its analogues has been shown to be consistent with 
the release of the HO• radicals from the enzymatically reduced TPZ• radical. The HO• radical 
is now thought to be the agent principally responsible for DNA damage. 
14
 [Shen 2014]  
Under normal oxygen conditions the intermediate free radical is rapidly oxidized back to 
TPZ. In cell lines TPZ been shown to be up to 450 times more cytotoxic in hypoxic compared 
to well-oxygenated cells, producing both single strand and double strand breaks. It is also 
known that severely hypoxic tumours require up to three times the radiation dose to kill 
tumours cells compared to oxic cells. 
15
 [Rowinsky 1999]  
Preclinical results showed a synergistic chemoradiation relationship between TPZ and CisPt 
against a number of tumours, which was also found in Phase II trials. 
16
 [Green 2016] 
However in a phase III trial a combined TPZ/CisPt chemoradiotherapy of cervical cancer was 
not found to be superior to standard CisPt chemoradiotherapy in either progression free 
survival or overall survival, although statistically there were inadequate progression or death 
events for a definitive result. A satisfactory TPZ/CisPt chemoradiotherapy starting dose was 
identified. 
17
 [DiSilvestro 2014] 
Despite promising results from a phase II trial of combined chemoradiotherapy of head and 
neck cancers using TPZ combined with CisPt, the phase III trial found no difference in 
patients (with advanced head and neck cancer not selected for the presence of hypoxia) in 
overall survival compared to CisPt chemoradiation alone. 
18
 [Rischin 2010] It is unknown 
why the phase III trials of DiSilvestro and Rischin failed to reproduce the promising in vitro 
results or phase II trials of TPZ/CisPt treatments. It is also unknown whether the observed 
synergy that was found in cell lines or the phase II trials is due to TPZ exerting its hypoxic 
effect or its sensitizing of CisPt. The radio-resistance of hypoxic cells is related to the high 
electron affinity of the oxygen molecule, which enables even small amounts of oxygen (ca 
0.01%) to fix radiation induced DNA damage before the damaged DNA can be restored by 
naturally occurring radical scavengers (eg thiols) in the cells. 
7
  [Pettersen 2014] In vitro, the 
tumour-specific potentiation of cisplatin cytotoxicity is thought to result from an interaction 
between TPZ and cisplatin at the cellular level that requires low oxygen levels less than 1%. 
A marked time dependent scheduling effect was observed, with an increased cell kill 
potentiation when TPZ preceded CisPt administration. 
19
 [Kovacs 1999] It is possible that 
varying levels of oxygen in tumours (median levels in various tumours span 0.1-4%) has 
confounded the phase III trial results, and drug delivery influences the relative intracellular 
concentrations of TPZ and CisPt and consequently intracellular oxygen levels which are 
critical to cell kill. 
 
TPZ appears to undergo significant metabolic conversion before reaching its cellular DNA 
target based on the large change in efficacy between in vitro conditions (50–300 fold) and the 
observed 3-5 fold found in preclinical in vivo studies. 
20-24
 [Denny 2009, Hicks 2006, Pruijn 
2005, 2008, Hay 2003] The activity of TPZ in tumours is known to be compromised by its 
inefficient penetration into the hypoxic tissue. Hypoxic cells are the most distant from the 
functional oxygen supplying vasculature, so efficient extravascular transport is required for 
optimal TPZ efficacy. Modelling of TPZ in the tumour microvascular region showed a lack 
of transport penetration into the region lowers the cell killing in the most hypoxic region of 
the tumour by seven logs of activity. It is also possible that the reductive metabolism of TPZ 
is fast enough to lower its penetration into hypoxic tissue, thereby lowering if efficacy. 
21
 
[Hicks 2006]   
 
Using an in vitro multilayered cell culture (MCC) model, when tirapazamine is administered 
via intravenous infusion, a stable TPZ distribution occurs within 15 minutes with cells most 
peripheral to the blood vessel were exposed to only 10% of the blood drug concentration. 
Extravascular penetration of TPZ to peripheral cells existing at low oxygen tension is limited 
by the metabolism of TPZ by more proximal cells existing at moderate oxygen tension, so 
TPZ is only significantly cytotoxic to cells located within ∼75 μm of blood vessels, 25 [Kyle 
1999] although other modelling suggests that hypoxic cells may be present within 25-50 μm 
of blood vessels. 
26
 [Ljungkvist 2002] Studies in mouse plasma and tumours have shown that 
peak plasma concentrations of TPZ were 26%, with the two electron reduction product, TPZ 
1-oxide, being ca 15%, and the four electron reduction product, TPA nor-oxide, being ca. 
1.5%. The KHT tumour:plasma ratio for TPZ was 32%, but for EMT6 tumours the ratio was 
only 7%. Extensive bioreduction metabolism occurred in tumour and normal tissue. 
27
 
[Walton 1993] These studies clearly point to TPZ delivery to the intended target, hypoxic 
tumour cells, is the limiting factor affecting drug efficacy, particularly in the blood supply.  
 
It has been suggested that the tumour microenvironment may be involved in the resistance of 
some solid tumour to chemotherapy, and that many anti-cancer drugs do not distribute 
efficiently and equally in body tissues. Poor and disorganized vascular networks, the absence 
of functional lymphatics that cause increased interstitial fluid pressure, and the composition 
and the structure of the extracellular matrix can slow down the transport of anti-cancer drugs 
within solid tumours. Hypoxia is a widely recognized hallmark of cancer in solid tumours. 
The microenvironment of solid tumours is known to be more acidic (pH 6.5–6.9) than the 
physiological pH of normal tissue (pH 7.2–7.5). Acidic microenvironments have been shown 
to increase the invasiveness of a tumor, leading to increased metastasis 
4,5
 [Tredan 2007, 
Minchinton 2006]. It has also been found that a low pH can substantially potentiate the 
cytotoxic effect of TPZ in aerobic HT-29 human tumour cells, but no such potentiation was 
observed under hypoxic conditions. 
28
 [Skarsgard 1993] Using a magnetic resonance 
imaging/PISTOL technique to directly measure oxygen levels in pre-clinical tumour models 
of NSCLC (H1975) and epidermoid carcinoma (A431) treated with TPZ, it was found that 
tumour growth was not directly related to oxygen levels, but other factors such as tumour 
permeation and TPZ bioreduction were probably involved as well as oxygen levels. 
29
 
[Agarwal 2015]  
 
The penetration of anti-cancer drugs into tumours is clearly a limiting factor in 
chemotherapeutic efficacy. 
2,4-6
 [Tredan 2007, Minchinton 2006, Vaupel 2010, Muz 2015] 
There are other factors related to the vascular blood supply that limit the delivery of anti-
cancer drugs to the targeted tumour sites. Recently there has been much interest in using 
cucurbit[n]urils (CB) as molecular delivery containers that enhance drug delivery to the 
intended target by protecting the drug from attack and degradation by biological agents. 
30-32
 
[Saleh 2013, Nau 2011, Walker 2011]  Many drugs have been found to be encapsulated 
within the cavity of  CB, particularly cucurbit[7]urils, CB[7], and it may that TPZ or some its 
analogues may also form inclusion complexes with CB[7]. If this were so, then the formation 
of TPZ@CB[7] inclusion complexes may be beneficial in delivering increased quantities of 
TPZ compared to free TPZ to tumours and so increasing anti-cancer efficacy within the 
tumour.   
 
We have previously developed a four parameter model that has been shown to apply to the 
transport and anti-cancer and metabolic efficacy of various drugs. The model, equation 1, is 
based on establishing linear free energy relationships between the four drug properties and 
various biological processes. Equation 1 has been previously applied to passive and 
facilitated diffusion of a wide range of drugs crossing the blood brain barrier, the active 
competitive transport of tyrosine kinase inhibitors by the hOCT3, OATP1A2 and OCT1 
transporters, and cyclin-dependent kinase inhibitors and HIV-1 protease inhibitors.  The 
model also applies to PARP inhibitors, the anti-bacterial and anti-malarial properties of 
fluoroquinolones, and active organic anion transporter drug membrane transport, and some 
competitive statin-CYP enzyme binding processes. There is strong independent evidence 
from the literature that ΔGdesolvation, ΔGlipophilicity, the dipole moment and molecular volume are 
good inherent indicators of the transport or binding ability of drugs. 
33-40
 [Fong 2015-16]. 
 
Equation 1: 
Transport or Binding = ΔGdesolvation + ΔGlipophilicity + Dipole Moment + Molecular Volume  
Or 
Transport or Binding = ΔGdesolv,CDS + ΔGlipo,CDS + Dipole Moment + Molecular Volume  
 
A modified form of equation 1 using the free energy of water desolvation (ΔGdesolv,CDS) and 
the lipophilicity free energy (ΔGlipo,CDS) where CDS represents the non-electrostatic first 
solvation shell solvent properties, may be a better approximation of the cybotactic 
environment around the drug approaching or within the protein receptor pocket, or the cell 
membrane surface or the surface of a drug transporter, than the bulk water environment 
outside the receptor pocket or cell membrane surface. The CDS includes dispersion, 
cavitation, and covalent components of hydrogen bonding, hydrophobic effects. Desolvation 
of water from the drug (ΔGdesolv,CDS) before binding in the receptor pocket is required, and 
hydrophobic interactions between the drug and protein (ΔGlipo,CDS) is a positive contribution 
to binding. ΔGlipo,CDS is calculated from the solvation energy in n-octane. In some biological 
processes, where oxidation or reduction may be occurring, and the influence of molecular 
volume is small, the ionization potential or reduction potential has been included in place of 
the molecular volume. In other processes, the influence of some of the independent variables 
is small and can be eliminated to focus on the major determinants of biological activity.  
The object of this study is to develop a quantum mechanical model based on identifying 
linear free energy relationships based on equation 1 which supplement the extensive 
multicellular layer pharmacokinetic/pharmacodynamic or structure activity modelling studies 
of Hicks, Pruijn and Hay 
21-24
 but may be more amenable to drug design by using in silico 
methods to examine molecular changes and their effects on biological activities. A secondary 
object is to see if TPZ can form inclusion complexes with CB[7] as a precursor to proof of 
principle of enhanced TPZ delivery to tumours which might be warrant further investigation. 
2. Materials and Methods 
 
All calculations were carried out using the Gaussian 09 package. Energy optimisations were 
at the DFT/B3LYP/6-31G(d,p) (6d, 7f) level of theory for all atoms. Selected optimisations at 
the  DFT/B3LYP/6-311
+
G(d,p) (6d, 7f) level of theory gave very similar results to those at 
the lower level. Optimized structures were checked to ensure energy minima were located, 
with no negative frequencies. Energy calculations were conducted at the DFT/B3LYP/6-
311+G(d,p) (6d, 7f) level of theory with optimised geometries in water, using the 
IEFPCM/SMD solvent model. With the 6-31G* basis set, the SMD model achieves mean 
unsigned errors of 0.6 - 1.0 kcal/mol in the solvation free energies of tested neutrals and mean 
unsigned errors of 4 kcal/mol on average for ions. 
41
 [Marenich 2009] The 6-31G** basis set 
has been used to calculate absolute free energies of solvation and compare these data with 
experimental results for more than 500 neutral and charged compounds. The calculated 
values were in good agreement with experimental results across a wide range of 
compounds.
42,43
 [Rayne 2010, Rizzo 2006] Adding diffuse functions to the 6-31G* basis set 
(ie 6-31
+
G**) had no significant effect on the solvation energies with a difference of less than 
1% observed in solvents, which is within the literature error range for the IEFPCM/SMD 
solvent model. HOMO and LUMO calculations included both delocalized and localized 
orbitals (NBO). 
 
Adiabatic electron affinities (AEA) in eV in water were calculated by the SCF difference 
between the optimised neutral and optimised radical species method as previously described. 
[Fong 2016] It has been shown that the B3LYP functional gives accurate electron affinities 
when tested against a large range of molecules, atoms, ions and radicals with an absolute 
maximum error of 0.2 eV. 
44-46
 [Rienstra-Kiracofe 2002, Peverati 2014, Riley 2007]  
It is noted that high computational accuracy for each species in different environments is not 
the focus of this study, but comparative differences between various species is the aim of the 
study. The literature values for Ds, DMCL, HCR, IC50 to develop the multiple regression LFER 
equations have much higher experimental uncertainties than the calculated molecular 
properties. The statistical analyses include the multiple correlation coefficient R
2
, the F test of 
significance, standards errors for the estimates (SEE) and each of the variables 
SE(ΔGdesolCDS), SE(ΔGlipoCDS), SE(Dipole Moment), SE (Molecular Volume), SE (AEA) as 
calculated from “t” distribution statistics. Residual analysis was used to identify outliers.  
 
For the TPZ inclusion complex with cucurbit[7]uril (TPZ@CB[7]), energy optimisations 
were done at the DFT/B3LYP/3-21G level of theory, and using a two layer ONIOM model, 
at the 6-31+G(d,p) levels for the high level TPZ moiety, and using the UFF force field or 
semi-empirical PM6 at the low level. Energy calculations were done at the DFT/B3LYP/6-
311+G(d,p)  level of theory. The wB97XD functional was used for the TPZ@CB[7] 
thermodynamic calculations. This functional is a long range corrected hybrid with damped 
dispersion correction which gives good results with non-covalent and covalent systems and 
have been shown to give quite accurate results when compared to experimental data.   
The free energy of formation of the {TPZ@CB[7]} complex ΔGform,Complex,sol in a particular 
solvent is calculated from the thermodynamic cycle at standard conditions, T = 298.15 K and 
P = 1 atm: 
ΔGform,Complex,sol = ΔGform,Gas + ΔGsolv,Complex – ΔGsolv,CB[7] - ΔGsolv,TPZ 
where ΔGform,Gas is the free energy of formation of the complex in the gas phase, and ΔGsolv is 
the free energy of solvation. The ΔGform,Complex are corrected for the BSSE (basis set 
supposition error) using the counterpoise method.  
 
The binding of TPZ analogues 10 and 12 (shown in Figure 2(c)) to DNA using the structures 
shown in Figure 3(a), the full model, and 3(b), the truncated model of the {DNA-TPZ 
analogues}, for the neutral and protonated acridine species, as well as the diprotonated 
analogue 12 were investigated using  the modified x-ray structure from PBD 366D 
58
 at the 
DFT/B3LYP/3-21G(d) level of theory for thermochemical analysis of the truncated model 
and the full model for energy. Energy calculations for the full model were also run using an 
Oniom model at the DFT/B3LYP/6-31+G(d) for the higher level and UFF for the lower level.  
Energy calculations for the truncated model were at the DFT/B3LYP/6-311+G(d,p) level of 
theory. Thermochemical analysis of the truncated model were also conducted at the 
DFT/wB97XD/3-21G(d) level of theory to test for significant dispersion effects between the 
intercalated acridine moieties and the guanine nucleobases, whereas the DFT/B3LYP/3-
21G(d) level may be more appropriate for testing for induction (from the permanent dipole of 
the charged acridine) mixed with dispersion. 
59
 The ΔHform,complex,sol for the {DNA-TPZ10} 
and protonated acridine complex {DNA-TPZ(H
+
)} were -34.6 and -22.8 kcal/mol 
respectively at the DFT/B3LYP/3-21G(d) and  -28.2 and -15.5 kcal/mol at the  
DFT/wB97XD/3-21G(d) level. It is unclear whether intercalation is driven by dispersion 
effects or a mixture of dispersion and induction, but these results show that the comparative 
differences between the two functionals is much the same for the unprotonated and 
protonated {DNA-TPZ} complexes. Corrections for the basis set supposition error using the 
counterpoise method were made. Solvation energies were calculated using the SMD model. 
In all cases, the HOMO was located on the guanine nucleobases of the DNA moiety for the 
neutral intercalated acridine species, but for the protonated acridine species, the HOMO was 
located on the two guanine bases and the intercalated N- protonated acridine in water and in 
vacuo.   
 
3. Results 
 
Hicks 2006 has used three-dimensional tissue cultures to model the extravascular transport 
and the vivo activity of range of TPZ derivatives. Hicks found that extravascular transport in 
tumours can be predicted by measuring drug penetration through colon cancer multicellular 
layers (MCL). A strong correlation was found between tumour drug levels generated using 
the extravascular transport model and hypoxic cell kill. Hay has examined the structure 
activity relationships amongst a range of TPZ analogues. 
24
 [Hay 2003] Pruijn 2005 
22
 has 
similarly shown that diffusion in MCL tumour tissue was sigmoidally dependent on 
lipophilicity (log P from octanol-water partitioning), inversely proportional to M
0.5 
(where M 
is the molecular weight), and strongly influenced cell kill. 
22
 [Pruijn 2005]  This study uses 
Hicks’, Hay’s and Pruijn’s experimental data to examine the applicability of eq 1 to the 
transport and tumour cell kill of the TPZ derivatives. All these studies were conducted in the 
same laboratory, which gives internally consistent data and eliminates the very large inter-
laboratory variability which introduces unknown data population statistical errors or biases 
found in many published QSAR or LFER studies of biological processes. 
33
 [Fong 2016]  
  
The structure of TPZ is shown in Figure 1 and the properties of the various analogues with 
substituents at positions 5, 6, 7 and 8 are given in Table 1. Figures 2(a),(b), and (c) show the 
TPZ analogues examined by Hicks, Pruijn and Hay 
21-24
 with a diverse range of 3-NH(R) 
substituents, with properties given in Table 1. All molecular properties in Table 1 were 
calculated using DFT/B3LYP/6-311
+
G(d,p) (6d, 7f) quantum mechanical methods as given in 
the experimental section.  
 
   
 
Figure 1. Tirapazamine (TPZ) 
 
 
 
Figure 2a. TPZ analogues from Hicks 2006 Supplement Table 1 
 
 
 
Figure 2b.  TPZ analogues from Pruijn 2008 Supplement Table 1 
 
 
 
Figure 2c. TPZ analogues from Hay 2004 Table 1: DNA binding constants 
 
3.1 Diffusion 
 
Diffusion of 14 TPZ derivatives and 3 reference compounds through the collagen coated 
artificial Teflon support membranes Ds from Pruijn 2005 Table 1 (acridone, mannitol, urea, 
TPZ, 6-Me, 7-Me, 8-Me, 7-SO2Me, 8-SO2Me, 6-Cl, 7-Cl, 8-Cl, 7-CF3, 8-CF3, 8-NEt2, PII, 
PIII) 
                                                                                                                     Eq 2                                                                                                                              
DS = -0.040ΔGdesolv,CDS +0.025ΔGlipo,CDS +0.034Dipole Moment -0.07Molecular Volume 
+1.90  
Where R2  = 0.846, SEE = 0.122, SE(ΔGdesolvCDS) = 0.040, SE(ΔGlipoCDS) = 0.026, SE(Dipole Moment) = 0.018, 
SE(Molecular Volume) = 0.002, F=16.47, Significance=0.0000 
 
Diffusion of 14 TPZ derivatives and 1 reference compound through the artificial Teflon 
support membranes coated with HT29 MCL, DMCL from Pruijn 2005 Table 1 (excluding 
acridone and urea as outliers) 
                                                                                                                       Eq 2a                                                                                                                              
DMCL = -0.267ΔGdesolv,CDS -0.225ΔGlipo,CDS -0.156Dipole Moment +0.02Molecular Volume 
-1.99  
Where R2  = 0.858, SEE = 0.333, SE(ΔGdesolvCDS) = 0.141, SE(ΔGlipoCDS) = 0.073, SE(Dipole Moment) = 0.060, 
SE(Molecular Volume) = 0.005, F=15.08, Significance=0.0003 
 
Diffusion of 32 TPZ derivatives through the artificial Teflon support membranes coated with 
HT29 MCL, DMCL from Pruijn 2005 Table 1, Pruijn 2008 Table S1, and Hicks 2006 
Supplemental Table 1 (excluding acridone and #13 as outliers) see Figures 2a and 2b. 
                                                                                                                       Eq 3                                                                                                                              
DMCL = -0.280ΔGdesolv,CDS -0.080ΔGlipo,CDS -0.128Dipole Moment -0.014Molecular 
Volume -0.585  
Where R2  = 0.474, SEE = 0.530, SE(ΔGdesolvCDS) = 0.084, SE(ΔGlipoCDS) = 0.077, SE(Dipole Moment) = 0.051, 
SE(Molecular Volume) = 0.031, F=5.57, Significance=0.0024 
 
Diffusion of 14 TPZ derivatives and 3 reference compounds as radical anions through the 
collagen coated artificial Teflon support membranes Ds from Pruijn 2005 Table 1 
                                                                                                                     Eq 4                                                                                                                              
DS = -0.077ΔGdesolv,CDS +0.056ΔGlipo,CDS -0.007Dipole Moment -0.02Molecular Volume 
+2.035  
Where R2  = 0.870, SEE = 0.112, SE(ΔGdesolvCDS) = 0.053, SE(ΔGlipoCDS) = 0.020, SE(Dipole Moment) = 0.016, 
SE(Molecular Volume) = 0.002, F=20.02, Significance=0.000 
 
Diffusion of 14 TPZ derivatives and 1 reference compounds as radical anions through the 
artificial Teflon support membranes coated with HT29 MCL, DMCL from Pruijn 2005 Table 1 
(excluding acridone and urea as outliers) 
                                                                                                                       Eq 5                                                                                                                              
DMCL = -0.447ΔGdesolv,CDS -0.300ΔGlipo,CDS +0.039Dipole Moment -0.12Molecular Volume 
-2.175  
Where R2  = 0.823, SEE = 0.370, SE(ΔGdesolvCDS) = 0.193, SE(ΔGlipoCDS) = 0.075, SE(Dipole Moment) = 0.061, 
SE(Molecular Volume) = 0.008, F=11.65, Significance=0.001 
 
NB: Eqs 2-5 use molecular volumes which are 0.1 times the raw values (which ca. >10 times 
larger than the other 3 variables) to place these values on a comparative normalized basis.   
3.2 Antiproliferative assays IC50 
 
IC50 μM of 14 TPZ derivatives hypoxic HT29 cells  Hicks Supplemental Table 1 (excluding 
compounds 2 and 6 as outliers) 
                                                                                                                      Eq 6                                                                                                                              
IC50 = 0.04ΔGdesolv,CDS +1.07ΔGlipo,CDS +0.74Dipole Moment +4.855AEA -7.74  
Where R2  = 0.626, SEE = 2.42, SE(ΔGdesolvCDS) = 0.76, SE(ΔGlipoCDS) = 0.41, SE(Dipole Moment) = 0.40, SE(AEA) = 
12.43, F=3.77, Significance=0.045 
 
 Or                                                                                                                     Eq 6a                                                                                                                              
IC50 = 1.09ΔGlipo,CDS +0.70Dipole Moment +2.78AEA -1.53 
Where R2  = 0.619, SEE = 2.32, SE(ΔGlipoCDS) = 0.39, SE(Dipole Moment) = 0.37, SE(AEA) = 10.81, F=5.43, 
Significance=0.017 
 
IC50 μM of 14 TPZ derivatives hypoxic HT29 cells as radical anions Hicks Supplemental 
Table 1 (excluding compounds 2 and 6 as outliers) 
                                                                                                                      Eq 7                                                                                                                              
IC50 = 0.10ΔGdesolv,CDS +0.51ΔGlipo,CDS +0.03Dipole Moment +15.63AEA -48.51  
Where R2  = 0.470, SEE = 2.88, SE(ΔGdesolvCDS) = 0.96, SE(ΔGlipoCDS) = 1.42, SE(Dipole Moment) = 0.46, SE(AEA) = 
13.40, F=1.99, Significance=0.18 
 
 or                                                                                                                  Eq 7a                                                                                                                              
IC50 = 0.42ΔGlipo,CDS +15.06AEA -47.29  
Where R
2  
= 0.468, SEE = 2.61, SE(ΔGlipoCDS) = 0.19, SE(AEA) = 9.75, F=4.84, Significance=0.031 
 
Eqs 6 and 7 were derived after showing that molecular volume had a very small influence on 
IC50. ΔGdesolv,CDS can be eliminated from both eqs 6a and 7a, and dipole moment can be 
eliminated from eq 7a as well in view of their minor contributions.  
 
3.3 Hypoxic cytotoxic ratio (HCR is the ratio of aerobic IC50 to anoxic IC50) 
 
HCR of 15 TPZ derivatives hypoxic HT29 cells  Hicks Supplemental Table 1 (excluding 
compound 7 as outlier) 
                                                                                                                      Eq 8                                                                                                                              
HCR = -3.68ΔGlipo,CDS +4.21Dipole Moment -88.43AEA +318.60  
Where R2  = 0.510, SEE = 34.18, SE(ΔGlipoCDS) = 5.24, SE(Dipole Moment) = 5.04, SE(AEA) = 143.26, F=3.83, 
Significance=0.042 
 
HCR of 15 TPZ derivatives as radical anions, hypoxic HT29 cells,  Hicks Supplemental 
Table 1 (excluding compound 7 as outlier) 
                                                                                                                      Eq 9                                                                                                                              
HCR = -51.38ΔGlipo,CDS -14.50Dipole Moment -62.43AEA +36.06  
Where R2  = 0.664, SEE = 32.58, SE(ΔGlipoCDS) = 13.98, SE(Dipole Moment) = 4.46, SE(AEA) = 119.51, F=7.24, 
Significance=0.006 
 
Eqs 8 and 9 showed very small dependencies on ΔGdesolv,CDS and molecular volume, so these 
variables were eliminated. 
 
Clonogenic assay data for 30 TPZ analogues as radical anions in SCCVII cells, C10(hyp) μM 
from Hay 2003 Table 2 
                                                                                                                      Eq 10                                                                                                                              
C10(hyp)  = -43.60ΔGdesolv,CDS  +46.29ΔGlipo,CDS +36.36Dipole Moment +50.47AEA +157.53  
Where R2  = 0.741, SEE = 50.20, SE(ΔGdesolvCDS) = 15.70, SE(ΔGlipoCDS) = 18.13, SE(Dipole Moment) = 5.52, SE(AEA) = 
76.94, F=17.92, Significance=0.000 
 
Clonogenic assay data for 29 TPZ analogues as radical anions in SCCVII cells, C10(aer) μM 
from Hay 2003 Table 2 
                                                                                                                      Eq 11a                                                                                                                              
C10(aer)  = 116.10ΔGdesolv,CDS  -246.84ΔGlipo,CDS -3.90Dipole Moment -2244.95AEA 
+8065.46  
Where R2  = 0.193, SEE = 1045.38, SE(ΔGdesolvCDS) = 327.57, SE(ΔGlipoCDS) = 387.07, SE(Dipole Moment) = 118.69, 
SE(AEA) = 1602.48, F=1.44, Significance=0.251 
 
  or                                                                                                                 Eq 11b                                                                                                                              
C10(aer)  = -2453.29AEA +8628.36  
Where R2  = 0.156, SEE = 1008.30, SE(AEA) = 1098.83, F=5.00, Significance=0.034 
 
Eq 11a and 11b (eliminating the non-significant dependencies on ΔGdesolv,CDS, ΔGlipo,CDS and 
dipole moment) for the aerobic assays are far poorer correlations than eq 10 for the hypoxic 
assay which may reflect some experimental discrepancies, and the HCR correlation is 
accordingly poor since HCR is the ratio of C10(aer): C10(hyp). Despite the low precision of the 
aerobic correlations, the reversal of dependency on the AEA is noteworthy and consistent 
with dominant free radical behaviour. 
 
3.4 Linear relationship between adiabatic electron affinity in water (AEA in eV) and the 
experimental E(1) in V determined by pulse radiolysis from Hay 2003, Table 1, for 
30 TPZ analogues.  
                                                                                                                               Eq 12a                                                                                                                              
AEA  = -1.451 E(1) + 4.208  
Where R2  = 0.672, SEE = 0.100, SEE(1) = 0.000, SEIntercept = 0.084, F=57.24, Significance=0.00000 
 
 
or  eliminating 4 large outliers (7Cl, 7CF3, 7NO2, 6CF3 analogues)                     Eq 12b                                                                                                                              
AEA  = -1.512 E(1) + 4.250  
Where R2  = 0.925, SEE = 0.041, SEE(1) = 0.000, SEIntercept = 0.040, F=295.04, Significance=0.00000 
 
3.5 Linear relationship between ΔGlipo,CDS and log P (experimental n-octanol/water 
partition coefficient) for 33 TPZ analogues taken from Hay 2003, Pruijn 2005, and 
Hicks 2006.  
                                                                                                                               Eq 13a                                                                                                                              
 ΔGlipo,CDS = -1.794 log P – 7.400  
Where R2  = 0.357, SEE = 2.784,  SElogP = 0.432, F=17.21, Significance=0.00024 
 
   or                                                                                                                         Eq 13b                                                                                                                              
 ΔGlipo,CDS = -1.083 log P – 7.093  
Where R2  = 0.389, SEE = 1.255,  SElogP = 0.283, F=14.62, Significance=0.00087 
 
Eq 13a includes several large outliers particularly compounds 12-15 from Hicks 2006 supplemental 
table 1, as shown in Figure 2, which are 3-NH-R compounds where R are large side chains with 
polycyclic aromatic groups, acridone, and the 6CF3,7CF3 and 8CF3 substituted TPZ analogues. 
However the linear relationship is highly significant, and there are known problems with some log P 
partitioning data. Eq 13b shows the correlation excluding the 8 outliers, where the SEE and SElogP 
are significantly lower than in eq 13a.  
 
3.6 DNA binding affinity of TPZ analogues 
 
Hay 
24b
 [Hay 2004] has shown that improved hypoxic tumour efficacy can be obtained by attaching 
DNA targeting substituents to TPZ, with the intention that substituents such as the DNA intercalating 
acridine moieties (chromophores) will bring the active TPZ moiety close to the target DNA such that 
improved cytoxicity will result. The binding constants KDNA 10
4
 M
-1
 are taken from Hay 2004 Table 1 
and the analogues are shown in Figure 2c. Hay has shown that binding affinity was dependent on the 
presence of a positive charge on the chromophore or the linking side chain as adjudged by calculated 
pKa values. In this study the neutral species, mono-protonated species (protonated at the side chain 
amine group or the chromophore group) and the di-protonated species (protonated at the side chain 
amine group and the chromophore group) were examined and tested against equation 1 to see if any 
indication could be discovered about where the TPZ analogues might be protonated when binding to 
DNA. Correlations against the neutral species, the mono-protonated side chain species and di-
protonated species were very poor. The best correlation was against the mono-protonated 
chromophores but only when compound 12 was considered as a di-protonated species (protonated at 
the acridine N and side chain N, and also when compound 13 was considered as the neutral species,  
otherwise these two compounds were large outliers from the correlation equation).   
                                                                                                                     Eq 14                                                                                                                              
KDNA = -14.51ΔGdesolv,CDS +5.60ΔGlipo,CDS +0.034Dipole Moment +0.31Molecular Volume 
-48.93  
Where R2  = 0.920, SEE = 6.00, SE(ΔGdesolvCDS) = 2.48, SE(ΔGlipoCDS) = 4.44, SE(Dipole Moment) = 0.43, SE(Molecular 
Volume) = 0.20, F=17.31, Significance=0.002 
 
Eq 14a shows the correlation in eq 14 but with the compound 13 as the protonated species 
where the correlation is significantly poorer, but shows the same characteristics with the 
DNA binding being dominantly driven by desolvation and lipophilicity. 
                                                                                                                     Eq 14a                                                                                                                              
KDNA = -9.49ΔGdesolv,CDS -2.90ΔGlipo,CDS +0.18Dipole Moment +0.19Molecular Volume -
120.76  
Where R2  = 0.749, SEE = 10.65, SE(ΔGdesolvCDS) = 4.39, SE(ΔGlipoCDS) = 7.30, SE(Dipole Moment) = 1.27, SE(Molecular 
Volume) = 0.43, F=4.47, Significance=0.051 
 
Hays’ binding study 24b [Hay 2004] contains no direct evidence about how the potentially DNA 
intercalating acridine moieties can bring the active TPZ moiety close to the target DNA so that 
improved cytoxicity will result. Molecular models of the interaction of TPZ analogues 10 and 12 (see  
Figure 2(c)) have been produced based on the x-ray structure of  N-(2-
(dimethylamino)ethyl)acridine-4-carboxamide (DACA) into DNA: X-ray structure 
complexed to d(CG(5-BrU)ACG)2 at 1.3 Å resolution. 
58
 [Todd 1999] The structure of 
{DNA-TPZ analogue12} complex is shown in Figure 3(a) along with a truncated model 
Figure 3(b) used to derive comparative binding constants between analogues 10 and 12 
(protonated and un-protonated forms in water) and the DNA moiety.  
  
 
Figure 3 (a) {DNA-TPZ analogue 10} complex showing acridine moiety intercalated 
between two guanine nucleobases of DNA moiety and Figure 3(b) showing the truncated 
model of Figure 3 (a) showing the TPZ analogue 12  with acridine moiety protonated at 
N and methyl group at position 9, and the aminopropyl side chain protonated at N and 
hydrogen bonded to the O of the nearby guanine nucleobase of the DNA moiety.  
 
Since eq 14 and 14(a) indicate that the binding of TPZ analogues to DNA is predominantly driven by 
desolvation and lipophilicity effects, the truncated model of the {DNA-TPZ analogues} has been 
investigated for analogue 10 and 12, for the neutral and protonated acridine species, as well as the 
diprotonated analogue 12, since eq 14(a) suggests this form may be dominant in equilibrated solution. 
H bond 
A thermochemical binding model which is routinely used to calculate binding in solution (see 
experimental) has been used which involves calculating the binding in vacuo, then correcting for the 
solvation of the complex using the solvation of the ligand and DNA individually. Only the 
comparative differences amongst the complexes are meaningful, since the model structure represents 
only a small portion of the {DNA-TPZ analogue} complexes, but the model should be able to 
differentiate between DNA interaction with neutral and protonated species, particularly since 
solvation effects would be quite different for charged versus neutral analogues. 
 
The free enthalpy of complex formation in solution, ΔHform,complex,sol of the TPZ10 analogue and 
its acridine N-protonated form is -34.6 and -22.8 kcal/mol, where the configurational entropy, 
TΔSform,complex,sol at 298.15K were -17.3 and -18.6 kcal/mol. For the {DNA complex-TPZ12 
analogue} model complex, ΔHform,complex,sol for the TPZ analogue and its acridine N-
protonated form were -35.7 and -31.0 kcal/mol, with TΔSform,complex,sol values of -17.2 and -
18.6 kcal/mol. For both analogues, the complex bindings in vacuo were greater for the 
acridine N-protonated forms, consistent with the highest occupied molecular orbitals HOMO 
for the complex being delocalized over the two guanine nucleobases and the intercalated 
acridine N-protonated moiety. This delocalization does not occur for the neutral species 
where the acridine moiety carries no formal charge. Despite the greater binding in vacuo for 
the acridine N-protonated complexes, the greater desolvation energy required for the charged 
TPZ analogues and the DNA moiety override the binding efficacy producing weaker total 
overall binding efficacy for the charged species in water. 
 
For the diprotonated TPZ12 analogue, the ΔHform,complex,sol is -54.3 kcal/mol, with 
TΔSform,complex,sol of -15.2 kcal/mol, which compared with the monoprotonated N-acridine 
complex of -31.0 and -18.6 kcal/mol respectively. This results shows that protonation of the 
side chain amino-propyl at N which allows hydrogen bonding to one of the guanine oxygen 
atoms (bond length 2.62 Å) substantially enhances complex binding (see hydrogen bond 
indicated in Figure 3(b)). 
 
3.7 DFT modelling of TPZ@CB[7] 
 
Figures 4(a) and (b) show an “internal configuration” of the TPZ@CB[7] complex in water, where the 
TPZ is inside the hydrophobic cavity region of CB[7]. Figure 4(c) shows the “external configuration” 
where the TPZ is attached to the polar carbonyl portal region of CB[7]. The free enthalpy of complex 
formation in solution, ΔHform,complex,sol of the internal configuration is -12.8 kcal/mol compared 
to -4.0 for the external configuration. These values suggest that these complexes may be 
stable and capable of synthesis. It is noted that these values include large configurational 
entropy TΔS and small ΔGform,complex,sol values, and were corrected for the basis set 
supposition error. A thermodynamic cycle was used for the free energy calculations. 
 
 
 
 
 
 
Figure 4(a)  TPZ@CB[7] complex internal configuration side view 
 
 
 
 
Figure 4(b)  TPZ@CB[7] complex internal configuration top view 
 
 
 
 
 
Figure 4(c)  TPZ@CB[7] complex external configuration  
 
 
Previous computational studies of the dynamics of guest insertion into the CB cavity have 
shown that high energy water in the cavity is expelled as the guest drug enters the 
hydrophobic cavity. 
31,40
 [Nau 2011, Fong 2017] In this study the configurations of the 
TPZ@CB[7] were varied from the “external configuration” to the “internal configuration” 
using the SMD solvent model. The SMD model calculates the solvation free energy as 
electrostatic component and the non-electrostatic component, ΔGCDS,water . The values of 
ΔGCDS,water vary smoothly from -19.0 to 13.6 kcal/mol depending how deeply embedded the 
TPZ is in the CB[7] cavity; and the degree of openness of the carbonyl group portals in the 
CB[7]. The carbonyl portal opening can be closed or open when inserting guest molecules. 
Using the ΔGCDS,water value as a measure of the free energy change as water molecules are 
expelled, a linear relationship has been found between the total energy of the solvated 
TPZ@CB[7] complex ΔEtotal,water for ten separate configurations moving from the “external” 
to the “internal” configuration and ΔGCDS,water:  
ΔEtotal,water = -26.6 ΔGCDS,water + 385.0 for n=10, R
2
 = 0.898, F = 80.54, significance = 0.0000  
This relationship gives an indication of the solvation energy changes involved in a TPZ 
molecule entering (and the reverse process leaving) the CB[7] cavity and may have relevance 
to how easily TPZ could be released from the TPZ@CB[7] complex. 
 
4. Discussion 
 
The accepted model of TPZ drug diffusion into the tumour (Figure 5) is (a) TPZ from the 
blood vessels surrounding the tumour enters the ECM and can permeate into the cells nearby 
the blood vessels where oxygen levels are high, so oxic cells have sufficient oxygen to 
prevent metabolism of TPZ and cytotoxicity  (b) the composition and structure of the ECM 
affects the rate of drug diffusion, the chemical and physical properties of the TPZ analogues 
affects the diffusion rate, and increased water solubility of drugs increases transport through 
the ECM compared to more lipophilic drugs which can permeate cell membranes more easily 
[5] [Minchinton 2006] (c) further diffusion of TPZ occurs through the ECM until it reaches 
the hypoxic regions of the tumour, where permeation into hypoxic cells can occur and 
metabolism can occur in the cytosol, and considerable binding of TPZ with proteins can also 
occur to reduce overall TPZ concentrations (d) TPZ can enter the nucleus where bioreduction 
occurs to produce the TPZ• and  HO• radicals which cause DNA damage. The extent of 
damage depends on the concentrations of the TPZ• and  HO• radicals and the oxygen tension. 
It is clear that there is a trade-off between the diffusion rate of a TPZ analogue (and the 
degree of metabolic consumption) and the rate of enzymatic reduction and consequent 
hypoxic cytoxicity.  
 
 
 
Figure 5. Schematic representation of extravascular transport of TPZ analogues and 
cytotoxicity of hypoxic tumour cell induced by bioreduction of TPZ to form radical 
species in cell nucleus. 
 
Multicellular layers (MCL) have been shown to be representative of many of the properties of 
solid tumours, such as the generation of an ECM, gradients of nutrient concentration and cell 
proliferation, and regions of hypoxia and necrosis in thicker layers. MCL are effective 
models for the extravascular region of tumours. 
5,21-24
 [Minchinton 2006, Hicks 2006, Pruijn 
2005,2008 and Hay 2003]  
 
4.1 Diffusion of TPZ analogues 
 
We have previously shown that the general form eq 1 applies to simple and facilitated 
diffusion of a range of drugs crossing the blood brain barrier. 
34
 [Fong 2015]  Eqs 2a and 2b 
can be directly compared to assess the difference in diffusion for the test set of TPZ 
derivatives between the collagen coated Teflon support membrane (which has a porosity of 
11%, and pore size of 0.4 μm) and the MCL coated membrane. The DMCL equation shows a 
negative increased dependency on the desolvation, lipophilicity and dipole moment compared 
to the DS equation 2 but no change in dependency on molecular volume. Eq 2 represents 
Fickian diffusion behaviour as shown by Pruijn 
22,23
 so the some degree of desolvation occurs 
as the TPZ drugs pass through the support membrane and the MCL, and hydrophobic (or 
lipophilic) and polar (dipole moment) interactions are of almost equal importance in 
determining the diffusion rates, whilst the influence of molecular volume has positive 
dependency on diffusion. 
 
Eq 3 shows a larger set of TPZanalogues than in eq 2a and 2b, notably the addition of a 
number of analogues which have large side chains as shown in Figures 2a and 2b which have 
been added to the analogues in Pruijn 2005 
22
. Comparison of eq 2b with eq 3 shows that the 
principal difference is the greater influence of lipophilicity, as shown by the larger ΔGlipo,CDS 
value in eq 3. This outcome is in accord with the expected increased influence of the large 
lipophilic side chain analogues. However the influence of water desolvation, dipole moment 
and molecular volume is similar between eq 2b and eq 3. The influence of molecular volume 
is much larger than those exerted by lipophilicity, desolvation and dipole moment, suggesting 
that the primary mechanism of diffusion in this system is driven by desolvation of the TPZ 
analogues prior to entering the cellular membrane, followed by a polar or electrostatic 
interaction between the desolvated analogue and the outer hydrophilic head groups of the 
membrane phospholipid bilayer, followed by the ease that more lipophilic analogues can then 
permeate into the inner hydrophobic membrane bilayer, where molecular volume also has a 
large influence.
34
 [Fong 2015] 
 
Eq 3 can be compared with the equation derived by Pruijn 2008 
23
 where log DMCL = a + b 
logMW + c / 1+ exp {(log P7.4 – x + y.HD + z.HA)/w} where MW is the molecular weight, 
log P7.4 is the octanol-water partition coefficient at pH 7.4, HD is the number of hydrogen 
bond donors, HA is the number of hydrogen bond acceptors, a is a constant, and b, c, x, y, z 
and w are statistically fitted coefficients. This equation is highly statistically significant, but 
does have 6 fitted coefficients. Eq 3 is similar to this equation in that lipophilicity and 
molecular volume are similar to logP7.4  and MW, dipole moment is similar to hydrogen 
bonding ability in that it represents dipolar interactions between the drug and the cell 
membrane, but there is no desolvation equivalent term in the Pruijn equation. We have 
previously shown that desolvation is a significant factor in cell membrane permeation and 
facilitated diffusion (as well as active transport processes).  
33,35,25,38
 [Fong 2015, 2016]  
 
Eq 4 and 5 show the diffusion behaviour if the TPZ species were anion radicals. This 
hypothetical situation (which assumes that diffusion of radical species is similar with that of 
neutral species but it is the charge on the radical anion which ultimately determines diffusion 
of these species) could exist under certain clinical situation where for example where ionizing 
radiation was being used, with TPZ acting as a radiosensitizer 
47
 [Seiwert 2006] such as 
might occur with when co-administered with cisplatin, or in hypoxic regions of a solid 
tumour, or where metabolic reduction had occurred. Pruijn 2005 
22
 found that most of the 
investigated analogues were metabolically stable in HT29 MCLs, but six of the compounds 
with electron withdrawing substituents (7- and 8-SO2Me, 5- and 8-Cl, 7- and 8-CF3) were 
metabolized significantly. There is a 6 fold change in sensitivity for all 4 independent 
variables between eq 4 and 5, and Eq 3 can also be directly compared to eq 5, which is more 
relevant to possible clinical situations. Eq 5 shows a greater dependency on desolvation and 
positive dependency on dipole rather than a negative dependency for the neutral species. This 
observation is consistent with the increased charge spread over the TPZ moiety in the radical 
ions interacting with cellular electrochemical membrane potentials. 
34
 [Fong 2014] These data 
in eq 2-5 have implications for drug design since it is clear that transport of TPZ derivatives 
to its DNA target is dominated by desolvation, lipophilicity and dipole moment for the 
neutral species and may be even more so for radical species where desolvation and dipole are 
large factors. Molecular size is a minor contributor to the diffusion of the TPZ compounds. 
 
Since it has been shown 
10
 [Evans 1998] that enzymatic reduction of TPZ within the nucleus 
is the main mechanism of DNA damage (in human lung cancer cells), and that radical species 
formed outside the nucleus do not contribute to DNA damage, then the rate determining TPZ 
passive diffusion mechanism into the cell predominantly involves the neutral TPZ species, as 
portrayed by eq 3, and not the radical species, as portrayed by eq 5. It is well known that 
charged species do not easily permeate cell membranes compared to neutral species. 
34
 [Fong 
2014]  Passive diffusion appears to be the dominant transport mode, since TPZ is not a 
known substrate for active drug transporters, and HT29 cells do not express significant levels 
of P-gp or MRP-1 or -2 
22,48
 [Pruijn 2005, Cummins 2002]   
 
4.2 Antiproliferative assays IC50 
 
The IC50 analyses eqs 7 and 7a for the radical TPZ analogues shows that anti-proliferation of 
hypoxic HT29 cells is dominated by the AEA, with a minor dependence on the lipophilicity. 
This results suggests that only electron transfer processes involving TPZ is important not any 
binding processes involving TPZ and DNA, since some larger dependences on desolvation, 
dipole and lipophilicity would be expected, similar to eq 6a, as has been found in other drug – 
membrane permeation interaction studies. 
34,38,39
[Fong 2015, 2016,2016]  TPZ is known to 
exerts its cytoxic effects without forming adducts with macromolecules such as DNA. 
15,49,50
 
[Rowinsky 1999, Inbaraj 2003, Daniels 1998] 
 
4.3 Hypoxic cytoxic ratio 
 
Eq  8 (as neutral species, but adding the AEA as separate extrinsic variable) and eq 9 (as 
radical anion species) for the HCR of 15 TPZ hypoxic derivatives in HT29 cells shows that 
the HCR is dominated by the dependency on the AEA as expected. However, eq 9 shows that 
the radical species show an equal dependence on the lipophilicity, ΔGdesolv,CDS, as well as the 
AEA. It is also noted that the HOMO of the radical anions resides over the TPZ moiety for 
the 15 analogues studied, with the exception of compound 12 which has a 3-NH(R) structure 
where R contains a 9-substituted acridine moiety. In this case the HOMO resides on the 
acridine group, which potentially makes this side chain more reactive than the other side 
chains studied, and possibly induces a different mechanism where the acridine group interacts 
with DNA. The 15 TPZ derivatives have a wide range of structural differences but the TPZ 
moiety is the locus of activity. 
 
The separate aerobic and hypoxic clonogenic assays for 30 TPZ analogues as radical anions 
in SCCVII cells are examined in eqs 10 and 11a, 11b. Eq 10 for the hypoxic assay shows a 
strong correlation with C10(hyp) with desolvation, lipophilicity, dipole and AEA. However the 
correlation with C10(aer)  is far weaker which results in a poor correlation with HCR (not 
shown) since HCR is the ratio of  C10(aer) : C10(hyp). Given the strong correlation with HCR in 
eq 9, this result suggests some experimental discrepancies with the C10(aer) data, which is 
surprising considering that the 30 TPZ analogues all have similar molecular structures with 
varying substituents, whereas the TPZ analogues tested in eq 9 have widely varying 
molecular structures. Eq 11b shows the correlation between C10(aer) and AEA only. Despite 
the low precision of the aerobic correlations, the reversal of dependency on the AEA in eqs 
10 and 11a or 11b is consistent with expected free radical behaviour where the aerobic 
behaviour is almost exclusively determined by the electron affinity of the TPZ analogues. 
Under aerobic conditions, it is thought that cellular toxicity is a result of reactive oxygen 
species, the superoxide radical which is much less toxic than the TPZ radical or hydroxyl 
radical, being formed by redox cycling of the TPZ radical with oxygen. 
51
 [Brown 1999] So 
under aerobic conditions, the clonogenic assay is dominated by the AEA dependency, 
whereas under hypoxic conditions, desolvation, lipophilicity, the dipole moment and AEA 
are equal contributors to cytoxicity, consistent with diffusion and or bioreduction processes 
being dominant. The C10(hyp) results are consistent with the processes involving permeation of 
the TPZ analogues into the nucleus and bioreduction in the nucleus to form the TPZ and 
hydroxyl radicals, which interact with DNA as shown in Figure 5.  
 
Since the TPZ analogues can permeate the cell membranes of oxic and hypoxic cells, but 
cytoxicity mainly occurs in the nucleus of hypoxic cells and not by radicals formed in the 
cytosol 
10
 [Evans 1998] then the C10(aer) results are then consistent with free radical processes 
alone occurring in the ECM (strong dependency on AEA) and do not involve any membrane 
or enzymatic interaction processes (where dependencies on desolvation, lipophilicity and 
dipole moment would be expected in the correlations).  The C10(aer) results are also consistent 
with involvement by the superoxide radical which is much less toxic than the TPZ radical or 
hydroxyl radical, being formed by redox cycling of the TPZ radical with oxygen. 
51
 [Brown 
1999] 
 
4.4 Linear relationship between adiabatic electron affinity in water (AEA in eV) and the 
experimental E(1) in V determined by pulse radiolysis 
 
Eq 12a and 12b show a strong linear relationship between the AEA and experimental E(1). 
Removing the 4 largest outliers, the 7Cl, 7CF3, 7NO2, 6CF3 analogues, which are all strong 
electron withdrawing substituents, gives a vastly improved correlation. The intercept of eq 
12b gives a value of 4.28eV, which is in agreement with the SHE, which is the reference 
standard for the E(1) experimental values. The absolute potential of the aqueous standard 
hydrogen electrode is generally taken to be either 4.28V or 4.44V, which are derived from 
values of ΔGS
*
(H
+
) of −1112.5 and −1098.9 kJ mol−1 respectively. The value of 4.44 V 
includes an estimate of the contribution due to the surface potential of water. However since 
the total charge is conserved in a reaction, the contribution due to the surface potential 
cancels out in a chemically balanced chemical reaction that occurs in a single phase. The 
SMD model uses a ΔGS
*
(H
+
) of −1112.5 kJ mol−1 and SHE value of 4.28 V. 41,52 [Ho 2016, 
Marenich 2009] This correlation gives confidence that DFT AEA calculations using the SMD 
water solvation model are good proxies for aqueous reduction potentials. Romalho 2004 
53
  
has examined five 8-substituted TPZ analogues and found that B3LYP/6-311
++
G(d,p) AEA 
calculations in water were in good agreement with experimental reduction potentials.  
 
4.5 Linear relationship between ΔGlipo,CDS and log P (experimental n-octanol/water 
partition coefficient) for 33 TPZ analogues 
 
Eqs 13a and 13b show highly significant correlations between ΔGlipo,CDS and log P, although 
there are a number of clear outliers: the 3-NH-R compounds where R are large side chains with 
polycyclic aromatic groups (compounds 12-15 in Figure 2), acridone, all of which are quite different 
molecules from the simple substituted TPZ derivatives, and the 6CF3,7CF3 and 8CF3 substituted TPZ 
analogues. Removing these outliers in eq 13b improves the correlation as adjudged by the lower 
standard errors (SE).  
 
However there are several difficulties with log P values derived from n-octanol-water partitioning 
experiments. Wet octanol solution is a poor proxy for proteins or biological membranes 
because it contains ~2M of water, and cyclohexane would be a much better proxy. A set of 
solvation parameters derived for the protein interior from protein engineering data was also 
different from octanol scale: it was close to cyclohexane scale for nonpolar atoms but 
intermediate between cyclohexane and octanol scales for polar atoms.
54,55
 [Radicza 1988, 
Lomize 2012] We have previously used n-octane as a proxy for proteins or biological 
membranes as its dielectric properties closely resemble cyclohexane, and its long 
hydrocarbon chain is a better match to biological lipids. Experimental problems have been 
experienced with very hydrophilic or very hydrophobic compounds, usually because of 
solubility issues, emulsion formation and the formation of micelles within the octanol phase, 
adsorption onto vessel walls). Other difficulties concerns compounds that can tautomerize or 
equilibrate between zwitterion and neutral form, and amphiphilic chemicals may behave as 
detergents. 
56,57
 [Braumann, 1986; Dearden and Bresnen, 1988].  
 
4.6 DNA binding affinity of TPZ analogues 
 
Eqs 14 or 14a show that DNA binding is largely driven by ligand desolvation and lipophilicity for the 
protonated chromophores. The X-ray studies of DNA intercalated acridines complexes such as 
DACA, N-(2-(dimethylamino)ethyl)acridine-4-carboxamide have shown that (a) the side 
chain amine is protonated and hydrogen bonds to one of the two N7 sites of guanine at the 
intercalation site, (b) the acridine is protonated at N10 (c) both acid and conjugate base forms 
of acridine can be seen in the crystal structure (pH of crystallization 6.5), and (d) a third 
spacer drug was found between the two duplexes and is present as the monocationic 
(conjugate base form) with a neutral acridine ring. 
58 
[Todd 1999] Clearly the DNA 
intercalation of DACA and similar compounds is complex and multiple mechanisms and 
species are possible in solution leading to the crystallized complex forms. It is conceivable 
that eq14 which includes compound 13 as the neutral acridine species, and which does not 
have an amine side chain, may be valid. It is noted that eq 14 has treated compound 12 as the 
dipotonated species and 13 as the neutral species. Eq 14a has treated compound 13 as the 
protonated species (and 12 as the diprotonated species). A possible rational for treating 
compound 12 as the diprotonated species (KDNA 56.2 10
4
 M
-1
) is that compound 10 which 
only differs from 12 by a –CH3 substituent at position 9 on the acridine ring has a KDNA 3.3 
10
4
 M
-1
. The substantial difference in KDNA appears at first sight unlikely to be solely due to 
the 9-methyl group substituent. 
 
The observed KDNA equilibrium constants are almost certainly a composite apparent constant 
comprised of several independent constants. From first principle and based on other 
observations of protein binding processes 
33,35,25,38
 [Fong 2014-16] it is expected that some 
degree of desolvation of water molecules must occur before the acridine or acridine-like TPZ 
analogues can intercalate into the DNA (which also presumably requires some desolvation to 
accommodate the acridine ring). Lipophilicity or hydrophobic bonding would also be an 
important interaction during the intercalation process. It is noted that the side chain of DACA 
lies in the major groove, such that the long axis of DACA is aligned with the long axis of the 
DNA base pairs. It was found that the optimised structures of the TPZ analogues in water in 
this study were closely consistent with the configuration observed in the DACA x-ray 
structures.  
 
The calculated binding energies of the {DNA-TPZ analogues} complexes are consistent with 
the equations 14 and 14(a) which show that binding of the TPZ analogues to DNA are mainly 
driven by desolvation and lipophilicity interactions of the protonated species. The DFT 
modelling of binding energies shows that desolvation of the of the TPZA analogues and the 
DNA moiety are the dominant drivers and that the N-protonated acridine analogues are more 
strongly bound to the DNA moiety in vacuo, but when desolvation is taken into account in 
the thermochemical cycle, the neutral species are more strongly intercalated with the two 
guanine nucleobases. However, they truncated model is not fully representative of DNA 
binding to the TPZ analogues, since it mainly calculates the intercalating binding of a small 
portion of a single helix, whereas the full DNA has two helixes which have numerous 
solvation sites, and the polar TPZ moiety itself is not included. The diprotonated TPZ12 
analogue complex with the DNA moiety does clearly show that diprotonation enhances 
binding over that of just the intercalated mono-protonated TPZ analogue, which can be an 
important process in binding equilibria as measured by eq 14 and 14(a). These data do 
support the notion proposed in Hay’s work that attaching substituents to TPZ that can 
complex (intercalate) with DNA in both neutral and protonated forms, thereby increasing the 
likelihood to DNA degradation and cellular cytotoxicity. It is clear that drug designing efforts 
aimed at enhancing TPZ anti-cancer efficacy must consider the impacts of desolvation and 
lipophilicity. 
 
4.7 DFT modelling of TPZ@CB[7] 
 
CB have been shown to confer increased stability to encapsulated drugs possibly by protecting the 
drug from reactive species during delivery, including blood plasma protein binding, and oral drug 
administration is also feasible for some drugs, eg cisplatin@CB[7]. CB[7] is the optimum sized CB 
for many drugs, and the increased solubility and bioavailability of many drug@CB[7] complexes is 
also an advantage.  Cellular uptake of several CB[7] complexes has been demonstrated (possibly by 
macrophages) so the possibility of intracellular as well as extracellular drug delivery may be possible 
under certain circumstances. However it is expected that extracellular drug delivery would 
predominate, since drugs bind with CB in a dynamic reversible equilibrium so the release of the 
encapsulated drug occurs “by itself” driven by the dissolution and the associated dilution effect. The 
timescale of release can vary from minutes to hours for various complexes. CB also favour the 
binding of protonated forms of drugs, known as pKa shifts, that may be relevant in tumours where the 
pH is usually slightly acidic. 
30,32
 [Saleh 2013, Walker 2011]   
 
The modelling results of this study suggest that a TPZ@CB[7] complex may be quite stable, and that 
release of the TPZ from the complex is also feasible. A TPZ@CB[7] could offer an alternative drug 
delivery vehicle approach to the conventional structure activity approach to improving drug transport 
and efficacy. 
 
5. Conclusions 
 
Using the multiparameter model (desolvation, lipophilicity, dipole moment, and molecular 
volume and/or adiabatic electron affinity) as per general equation 1, which has been shown to 
apply to a wide range of other biological processes, it is found that the model applies to the 
diffusion, antiproliferative assays IC50 and aerobic and hypoxic clonogenic assays for a wide 
range of TPZ analogues in MCL. The neutral and radical anion forms of the TPZ analogues 
have been investigated to find the dominant factors which dictate behaviour under aerobic 
and hypoxic conditions. Extravascular diffusion is governed by the desolvation, lipophilicity, 
dipole moment and molecular volume, similar to passive and facilitated permeation through 
the blood brain barrier and other cellular membranes. Hypoxic assay properties of the TPZ 
analogues show dependencies on the electron affinity, as well as lipophilicity and dipole 
moment and desolvation, similar to other biological processes involving permeation of 
cellular membranes, including nuclear membranes. Aerobic properties are dependent on the 
almost exclusively on the electron affinity, consistent with electron transfer involving free 
radicals being dominant with little or no drug permeation of membranes and most likely 
occurring in the ECM. As MCL are known to be an effective model of the extravascular 
compartment for solid tumours, these results have design implications for possibly enhancing 
the anti-cancer efficacy of TPZ analogues.  
 
It has also been shown that a strong linear relationship exist between the adiabatic electron 
affinities and reduction potential in water of these TPZ analogues measured by pulse 
radiolysis. Similarly the calculated lipophilicity measure, ΔGlipo,CDS,  and the experimental 
water-n-octanol partition coefficients, log P, are well correlated, despite the known problems 
with such partitioning experiments.   
 
From an examination of the application of the general equation 1 to the DNA binding 
equilibrium constants of a series of TPZ analogues with acridine or acridine-like moieties, it 
is concluded that ligand water desolvation and lipophilicity are the dominant processes 
governing the DNA intercalation of TPZ analogues. DFT modelling of the complexes formed 
by TPZ analogues with neutral and N-protonated acridine moieties which intercalate with the 
guanine DNA nucleobases is also consistent with the results from applying equation 1 to 
measured equilibrium constants. 
 
The correlations allow changes in the molecular structures of TPZ analogues to be made by 
drug designers and consequent integrated prediction of drug transport, antiproliferation, 
aerobic and hypoxic efficacy.   
 
DFT QM modelling has shown that TPZ should form stable inclusion complexes with CB[7] 
and would be expected to dynamically release TPZ in aqueous environments.  
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Table 1.   Properties of TPZ analogues 
 
 Neutral Species TPZ Analogues Radical Anion Species TPZ Analogues 
Hay 2003 
Figures 1 
& 2 
CDSwater  
kcal/mol 
CDSoctane 
 kcal/mol 
Dipole 
Moment 
Water    D 
Molecular 
Volume  
Water 
cm3/mol 
CDSwater 
kcal/mol  
CDSoctane  
kcal/mol 
Dipole 
Moment 
Water    D 
Molecular 
Volume 
Water 
cm3/mol  
Adiabatic 
Electron 
Affinity 
Water eV 
H 5.27 -6.19 3 115 5.01 -6.11 5 134 3.58 
8NEt2 6.15 -7.52 5.7 174 5.85 -7.25 11.2 193 3.39 
8NMe2 5.54 -6.75 4.4 138 5.1 -6.46 8.3 122 3.4 
8OMe 6.31 -5.66 3.2 135 6.1 -5.54 5.5 146 3.55 
8Me 5.41 -6.4 3.2 119 5.2 -6.23 5.35 144 3.47 
8F 5.8 -5.62 4.1 122 5.6 -5.43 5.74 116 3.64 
8Cl 5.19 -6.65 3.85 107 4.94 -6.4 5.23 126 3.65 
8CF3 6.8 -5.29 5.5 124 6.6 -5.2 5.45 153 3.74 
8SO2Me 5.78 -6.14 7.4 141 5.6 -6.04 4.7 173 3.81 
8SO2Bu 6.3 -8.13 7.2 217 6.1 -8 7.1 245 3.8 
7NMe2 5.6 -6.64 7.5 153 5 -6.5 11.4 133 3.44 
7OMe 6.7 -5.77 3.4 146 6.4 -5.6 6.9 130 3.52 
7Me 5.7 -6.47 4.14 122 5.5 -6.4 6.9 137 3.52 
7F 5.91 -5.49 2.9 133 5.7 -5.4 4.8 132 3.66 
7Cl 5.3 -6.5 2.73 142 5.1 -6.5 5.3 120 3.51 
7CF3 7.2 -5.05 3.43 147 7 -4.96 5.8 165 3.33 
7SO2Me 6.2 -6.27 7.7 164 6 -6.13 7.07 165 3.79 
7NO2 8.1 -6.52 12.8 153 8.2 -6.51 6.9 127 4.07 
6NMe2 6 -6.51 9.8 146 4.9 -6.44 13.2 169 3.28 
6OMe 6.7 -5.7 5.65 182 6.35 -5.6 9.35 147 3.49 
6Me 5.73 -6.4 4.33 119 5.73 -6.4 6.38 141 3.5 
6F 5.95 -5.44 1 119 5.73 -5.4 4.1 113 3.61 
6Cl 5.3 -6.45 0.7 117 5.1 -6.4 5.1 139 3.66 
6CF3 7.23 -5 1.3 129 7.23 -5 5.1 145 3.59 
6SO2Me 6.3 -6.3 5.8 143 6.1 -6.22 6.5 165 3.86 
5NEt2 5.99 -7.37 5.87 177 5.72 -7.2 12.6 189 3.42 
5NMe2 5.1 -7.37 11 145 5.4 -6.46 5.9 150 3.42 
5OMe 6.3 -5.67 4.1 157 6 -5.53 7.8 131 3.56 
5Cl 5.21 -6.55 2.35 123 5 -6.5 5.5 130 3.64 
5F 5.8 -5.58 2.6 116 5.57 -5.45 5 120 3.65 
Acridone 4.66 -6.73 9.4 167 4.56 -6.73 11.52 148  
Mannitol 4.82 -3.37 3.1 127 4.84 -3.33 11.67 147  
Urea 3.43 -0.5 6.37 53 3.28 -0.16 5.57 53  
PII 7.03 -10.2 3.76 180 6.86 -10.16 5.22 174  
PIII 8.8 -10.8 4.45 208 8.61 -10.72 8.84 225  
Hicks  
2006 
Figure 2 
         
TPZ 5.2 -6.2 3.2 92 5 -6.1 5 134 3.58 
#1 6Me 5.73 -6.42 4.4 136 5.5 -6.3 7.6 148 3.5 
#2 7Cl 5.3 -6.6 2.7 102 5.3 -6.6 9.5 124 3.51 
#3 8Cl 5.2 -6.6 3.8 128 5 -6.5 5.8 143 3.65 
#4 7 
SO2Me 
6.3 -6.4 7.8 160 6.1 -6.3 9 205 3.79 
#5 Morph 3 -8.8 3.6 189 2.9 -8.56 11.6 198 3.59 
#6 NPr2 5.4 -9.6 2.4 258 5 -9.3 15.2 232 3.59 
#7 3.24 -7.9 3 199 3 -7.65 7.2 173 3.52 
#8 3.5 -8 3.6 206 3 -7.66 7.5 181 3.53 
#9 6OMe 4.15 -7.26 5.65 189 3.8 -7.65 7 221 3.5 
#10  3Et 5.84 -5.63 5 122 5.7 -5.6 3.9 141 3.62 
#11  
3EtOMe  
6.87 -5.5 5 145 6.7 -5.5 1.5 153 3.65 
#12 6.7 -14.84 10.1 374 6.6 -14.6 34.5 347 3.52 
#13 6 -15.23 14.3 405 5.83 -14.9 31.4 402 3.59 
#14 6.6 -15.4 12.1 465 6.1 -15.1 32.2 325 3.6 
#15 7.85 -16 13.1 451 7 -15.3 32.5 382 3.55 
          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
